Font Size: a A A
Keyword [pharmaceuticals]
Result: 181 - 200 | Page: 10 of 10
181. Synthons by catalytic oxidative carbonylation of arenes: From polymers to pharmaceuticals
182. Biodegradation of pharmaceuticals by microorganisms
183. Performance evaluation and characterization of an innovative membrane bioreactor in the treatment of wastewater and removal of pharmaceuticals and pesticides
184. Ambient ionization mass spectrometry for the forensic screening of pharmaceuticals and the determination of potential drug candidates
185. Chemical stability of amorphous pharmaceuticals prepared with silicates
186. Fate of pharmaceuticals in drinking water utilities
187. Examining granular activated carbon adsorption of organic contaminants from water: Endocrine disruptors/pharmaceuticals, methyl tert-butyl ether, and benzene
188. Effects of pharmaceuticals and personal care products in benthic invertebrates
189. Effect of drinking water ozone treatment on select pharmaceuticals and personal care products (PPCPs) and endocrine disrupting compounds (EDCs)
190. Highly enantioselective transition metal-catalyzed hydrogenation reactions: An efficient tool for the synthesis of pharmaceuticals and other bioactive molecules
191. Stabilization of amorphous pharmaceuticals by excipients
192. Occurrence and biodegradability of selected pharmaceuticals and personal care products
193. Reactive precipitation of pharmaceuticals: Mixing, reaction, and nucleation kinetics
194. Evaluation of novel polyethersulfone membranes incorporating charged surface modifying macromolecules for the removal of pharmaceuticals and endocrine disrupting compounds from drinking water
195. Analysis of selected pharmaceuticals and endocrine disrupting compounds and their removal by granular activated carbon in drinking water treatment
196. Chlorination of pharmaceuticals during water treatment
197. A bench-scale evaluation of the removal of selected pharmaceuticals and personal care products by UV and UV/hydrogen peroxide in drinking water treatment
198. Stability of amorphous pharmaceuticals: Prediction of onset of crystallization using experimental relaxation times
199. Evaluation of the phytotoxic effects of pharmaceuticals in aquatic higher plants
200. Quantification and identification of pharmaceuticals and their treatment by-products in drinking water and wastewater by LC/MS/MS
  <<First  <Prev  Next>  Last>>  Jump to